Journals / Çocuk Enfeksiyon Dergisi / 2014 / Cilt: 8 - Sayı: 2

Kırk Dokuz kawasaki olgusunun değerlendirilmesi: Bir retrospektif kohort çalışması

Clinical evaluations of 49 cases with kawasaki disease: A retrospective cohort study

Pages
64–70
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The cardiovascular complications in patients with Kawasaki disease are the reason that morbidity and mortality might be prevented by early diagnosis and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ı 2 m s rı Objective: Kawasaki disease is the most common cause of an acute febrile vasculitis with unknown etiol- ogy after Henoch-Schönlein purpura (HSP).
📊
Key Findings & Data:Material and Methods: The demographic and clinical characteristics and laboratory and treatment out- comes of patients with Kawasaki disease who were diagnosed between January 2005 and December 2010 were evaluated respectively.
💡
Conclusion & Impact:Conclusion: The cardiovascular complications in patients with Kawasaki disease are the reason that morbidity and mortality might be prevented by early diagnosis and treatment.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

ı 2 m s rı Objective: Kawasaki disease is the most common cause of an acute febrile vasculitis with unknown etiol- ogy after Henoch-Schönlein purpura (HSP). The aim of our study is to contribute data on Kawasaki disease, which may lead to severe cardiac complications and death when it is misdiagnosed or not treated appropri- ately. Material and Methods: The demographic and clinical characteristics and laboratory and treatment out- comes of patients with Kawasaki disease who were diagnosed between January 2005 and December 2010 were evaluated respectively. Results: Out of 49 patients, 17 of 49 (34.7%) were female and 32 of 49 (65.3%) were male. The female/ male ratio was 1.88. The average age of patients was 2.89±1.95 years. It was detected that the frequency of Kawasaki disease was increased in autumn and early winter, and the second peak was detected in June. Thirty-four of 49 (69%) patients had complete Kawasaki disease and 15 of 49 (31%) patients had incomplete disease. Changes in oral cavity concomi- tant fewer were the most frequent clinical findings (79.6%). Coronary artery abnormalities were detected in 13 of 49 patients (26.5%). Any significant correlation was found between abnormal echocardiography out- comes, and risk factors average age, duration of fewer, anemia, thrombocytosis, elevated erythrocyte sedimentation rate, positive C-reactive protein, elevat- ed serum transaminases, hyponatremia, and hypoal- buminemia. Conclusion: The cardiovascular complications in patients with Kawasaki disease are the reason that morbidity and mortality might be prevented by early diagnosis and treatment.

Özet

Amaç: Kawasaki hastalığı, etiyolojisi tam olarak bilin- meyen, çocuklarda Henoch-Schönlein vaskülitinden sonra en sık görülen akut febril bir vaskülittir. Çalışmamızın amacı tanı konulamadığında veya tanının gecikmesi durumunda ciddi komplikasyonlara veya mortaliteye neden olabilen Kawasaki hastalığının tanı ve yönetimine ait bilgi birikimine katkıda bulunmaktır. Gereç ve Yöntemler: Ocak 2005-Aralık 2010 tarihleri arasında kawasaki hastalığı tanısı konularak, takip edi- len 49 hastanın demografik ve klinik özellikleri ile labo- ratuvar ve tedavi sonuçları retrospektif olarak değer- lendirildi. Bulgular: Kawasaki tanısı alan hastaların 17’si (%34,7) kız, 32’si (%65,3) erkek olup kız/erkek oranı 1/1,88 idi. Hastaların yaş ortalaması 2,89±1,95 yıl ortanca 2,5 yıl idi. Hastalığın sonbahar ve erken kış aylarında daha sık görüldüğü, ikinci bir pikin ise haziran ayında yaşandığı saptandı. Hastaların 34’ü (%69) komplet, 15’i (%31) inkomplet Kawasaki hastalığı tanısı aldı. Hastalarda ateşe en sık eşlik eden bulgular olarak oral kavitede değişiklikler (%79,6) saptandı. Kırk dokuz hastanın 13’ünde (%26,5) koroner arter anormalliği tespit edildi. Koroner arter dilatasyonu saptanan 29 aylık ve dokuz aylık iki (%4,08) hastada dev anevrizma mevcuttu. Hastaların yaş grupları, ateş süresi, anemi, trombosi- toz, eritrosit sedimentasyon hızı (ESH) ve C reaktif protein (CRP) yüksekliği, hepatik transaminaz yüksek- liği, hiponatremi, hipoalbuminemi varlığı ile anormal ekokardiyografi bulguları karşılaştırıldığında istatistik- sel olarak anlamlı fark bulunmadı. Sonuç: Komplet ya da inkomplet bulgularla ortaya çıkabilecek Kawasaki hastalığında, erken tanı ve teda- vi ile mortalite ve morbiditenin en önemli nedeni olan kardiyovasküler komplikasyonların önlenmesi müm- kün olabilir.

🔖

Cite This Article

TOPÇU, S., AKGÜN, Ö. D., ÖZ, N., TANIR, G. (2014). Kırk Dokuz kawasaki olgusunun değerlendirilmesi: Bir retrospektif kohort çalışması. Çocuk Enfeksiyon Dergisi, Cilt: 8 - Sayı: 2, 64–70. https://ajindex.com/articles/193290

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fin- gers and toes in children. Allergy 1967; 16: 178-222
  2. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996; 94: 1379-85. [CrossRef] 3. Tullus K, Marks SD. Vasculitis in children and adolescents: clinical presentation, etiopathogenesis, and treatment. Paediatric drugs 2009; 11: 375-80. [CrossRef] 4. Bowyer S, Roettcher P. Pediatric rheumatology clinic popula- tions in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol 1996; 23: 1968-74
  3. Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic featu- res of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol 2012; 22: 216-21
  4. Burns JC, Newburger JW. Genetics insights into the pathogenesis of Kawasaki disease. Circ Cardiovasc Genet 2012; 5: 277-8. [CrossRef] 7. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H. Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J Epidemiol 2008; 18: 167-72. [CrossRef] 8. Rozo JC, Jefferies JL, Eidem BW, Cook PJ. Kawasaki disease in the adult: a case report and review of the literature. Tex Heart Inst J. 2004; 31(2):160-4
  5. Council on Cardiovascular Disease in the Y, Committee on Rheumatic Fever E, Kawasaki D, American Heart A. Diagnostic guidelines for Kawasaki disease. Circulation 2001; 103: 335-6. [CrossRef] 10. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-71. [CrossRef] 11. Song D, Yeo Y, Ha K, et al. Risk factors for Kawasaki disease- associated coronary abnormalities differ depending on age. Eur J Pediatr 2009; 168: 1315-21. [CrossRef] 12. Kuo HC, Yang KD, Chang WC, Ger LP, Hsieh KS. Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol 2012; 53: 4-11. [CrossRef] 13. Özsoylu Ş AN. Akut febril mukokütanöz lenf bezi sendromu. Çocuk Sağlığı ve Hastalıkları Dergisi 1976; 19: 57-60
  6. Kanra G CA, Kara A, Seçmeer G, Ceyhan M.Kawasaki Hastalığı: dokuz vakanın takdimi. Çocuk Sağlığı ve Hastalıkları Dergisi 1999; 42: